Allergic contraindication, use in pregnancy to be addressed in CDC guidance. Advisory committee urges language be modified to clarify that those with severe food and environmental allergies may receive the vaccine. At press briefing after FDA grants emergency use authorization to Pfizer/BioNTech’s COVID vaccine for persons in the US 16 years of age and older, CBER's Peter Marks addresses the 'foolhardy' conjecture that one dose is adequate.
The US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) has advised the agency to clarify the scope of the allergy contraindication for Pfizer Inc./BioNTech SE’s COVID-19 vaccine.
At a 12 December emergency meeting convened hours after FDA's Friday night emergency use authorization for the vaccine, ACIP members...